Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan

计划入组 100 人 · 首次发布于 2007 年 7 月 25 日

Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

计划入组 4 人 · 首次发布于 2020 年 9 月 16 日

carDIo-ttranSSfOrm nucLEar Imaging Study

计划入组 4 人 · 首次发布于 2022 年 2 月 28 日

Nuclear hormone receptor gene therapies (Ocugen)

nuclear receptor antagonist

NR2F6 nuclear receptor inhibitor

NANO Nuclear Energy

DEPARTMENT OF NUCLEAR MEDICINE

India

Precision Nuclear of Virginia

United States

Ocugen's OCU410ST Receives EMA Orphan Designation for Stargardt Disease

Egetis Therapeutics to Explore Tiratricol (Emcitate®) for Resistance to Thyroid Hormone Beta (RTHβ)

Ocugen's OCU410ST Receives EMA Orphan Drug Designation for ABCA4-Associated Retinopathies